Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients

被引：2
|
作者：
Pettine, Loredana [1 ]
Bortolotti, Marta [2 ]
Fattizzo, Bruno [1 ,2 ]
Da Via, Matteo C. [1 ,2 ]
Consonni, Dario [3 ]
Pompa, Alessandra [1 ]
Bolli, Niccolo [1 ,2 ]
Baldini, Luca [1 ,2 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Unit, Milan, Italy
[2] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy
来源：
HEMATOLOGICAL ONCOLOGY | 2023年 / 41卷 / 01期
关键词：
multiple myeloma; response to vaccination; SARS-CoV-2; IMMUNE-RESPONSES; VACCINES;
D O I：
10.1002/hon.3051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：210 / 212
页数：3
相关论文
共 50 条
  • [1] Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
    Bird, Sarah
    Panopoulou, Aikaterini
    Shea, Robyn L.
    Tsui, Micky
    Saso, Radovan
    Sud, Amit
    West, Sharon
    Smith, Katy
    Barwood, John
    Kaczmarek, Ewa
    Panlaqui, Carmela
    Kaiser, Martin
    Stern, Simon
    Pawlyn, Charlotte
    Boyd, Kevin
    LANCET HAEMATOLOGY, 2021, 8 (06): : E389 - E392
  • [2] SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
    Gavriatopoulou, Maria
    Ntanasis-Stathopoulos, Ioannis
    Korompoki, Eleni
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    HEMASPHERE, 2021, 5 (03):
  • [3] Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
    Enssle, Julius Christoph
    Moter, Alina
    Campe, Julia
    Gessner, Alec
    Yu, Ika Weijia
    Wolf, Sebastian
    Steffen, Bjorn
    Serve, Hubert
    Bremm, Melanie
    Huenecke, Sabine
    Lohoff, Michael
    Vehreschild, Maria
    Rabenau, Holger F.
    Widera, Marek
    Ciesek, Sandra
    Rieger, Michael A.
    Imkeller, Katharina
    von Metzler, Ivana
    Ullrich, Evelyn
    BLOOD, 2022, 140 : 1826 - 1827
  • [4] Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
    Greenberg, Ross S.
    Ruddy, Jake A.
    Boyarsky, Brian J.
    Werbel, William A.
    Garonzik-Wang, Jacqueline M.
    Segev, Dorry L.
    Imus, Philip H.
    BMC CANCER, 2021, 21 (01)
  • [5] Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
    Ross S. Greenberg
    Jake A. Ruddy
    Brian J. Boyarsky
    William A. Werbel
    Jacqueline M. Garonzik-Wang
    Dorry L. Segev
    Philip H. Imus
    BMC Cancer, 21
  • [6] Response to SARS-CoV-2 vaccination in patients with Multiple Myeloma using a 12-week spaced dosing strategy
    Bird, Sarah
    Panopoulou, Aikaterini
    Shea, Robyn
    Tsui, Micky
    Saso, Radovan
    Sud, Amit
    West, Sharon
    Smith, Katy
    Barwood, John
    Kaczmarek, Ewa
    Panlaqui, Carmela
    Kaiser, Martin
    Stern, Simon
    Boyd, Kevin
    Pawlyn, Charlotte
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S114 - S114
  • [7] Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma
    Malard, Florent
    Gaugler, Beatrice
    Gozlan, Joel
    Bouquet, Lucie
    Fofana, Djeneba
    Van De Wyngaert, Zoe
    Ikhlef, Souhila
    Marjanovitch, Zora
    Morand-Joubert, Laurence
    Mohty, Mohamad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S117 - S117
  • [8] Vaccination against SARS-CoV-2 in patients with multiple sclerosis
    Costa-Frossard, Lucienne
    Garcia-Dominguez, Jose M.
    Moreno-Torres, Irene
    Fortun, Jesus
    Villar, Luisa M.
    Meca-Lallana, Virginia
    REVISTA DE NEUROLOGIA, 2021, 72 (07) : 250 - 260
  • [9] Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
    Woopen, Christina
    Schleussner, Katharina
    Akgun, Katja
    Ziemssen, Tjalf
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
    Allman, M.
    Tallantyre, E.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY, 2022, 269 (04) : 2259 - 2261
12345